Spain Endoscopic Retrograde Cholangiopancreatography Market

ID: MRFR/HC/50306-HCR
200 Pages
Rahul Gotadki
Last Updated: February 06, 2026
Spain Endoscopic Retrograde Cholangiopancreatography Market Research Report By Procedure (Biliary Sphincterotomy, Biliary Stenting, Biliary Dilatation, Pancreatic Duct Stenting, Others), By End-user (Hospitals & Clinics, Ambulatory Surgical Centers), By Application (Bile Duct, Pancreas, Others), and By Product (Endoscopes, Imaging Devices, Energy Devices) - Growth & Industry Forecast 2025 To 2035
Spain Endoscopic Retrograde Cholangiopancreatography Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)9.74%
2024 Market Size$ 45.68 Million
2025 Market Size$ 50.13 Million
2035 Market Size$ 126.93 Million
Key Players
Boston Scientific
Medtronic
Olympus Corporation
Cook Medical
Fujifilm Holdings Corporation
Conmed Corporation
Trends
  • Technological Advancements
  • Regulatory Changes
  • Increased Patient Awareness
Opportunities
  • Government Initiatives and Funding
  • Advancements in Endoscopic Technology
  • Rising Incidence of Biliary Disorders
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Construction, BY Procedure (USD Million)
      1. 4.1.1 Biliary Sphincterotomy
      2. 4.1.2 Biliary Stenting
      3. 4.1.3 Biliary Dilatation
      4. 4.1.4 Pancreatic Duct Stenting
      5. 4.1.5 Others
    2. 4.2 Construction, BY End User (USD Million)
      1. 4.2.1 Hospitals & Clinics
      2. 4.2.2 Ambulatory Surgical Centers
    3. 4.3 Construction, BY Application (USD Million)
      1. 4.3.1 Bile Duct
      2. 4.3.2 Pancreas
      3. 4.3.3 Others
    4. 4.4 Construction, BY Product (USD Million)
      1. 4.4.1 Endoscopes
      2. 4.4.2 Endotherapy Devices
      3. 4.4.3 Catheters
      4. 4.4.4 Stents
      5. 4.4.5 Balloons
      6. 4.4.6 Guiding Wires
      7. 4.4.7 Others
      8. 4.4.8 Imaging Devices
      9. 4.4.9 Energy Devices
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Construction
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Boston Scientific (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Medtronic (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Olympus Corporation (JP)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Cook Medical (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Fujifilm Holdings Corporation (JP)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Conmed Corporation (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Hoya Corporation (JP)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 B. Braun Melsungen AG (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SPAIN MARKET ANALYSIS BY PROCEDURE
    3. 6.3 SPAIN MARKET ANALYSIS BY END USER
    4. 6.4 SPAIN MARKET ANALYSIS BY APPLICATION
    5. 6.5 SPAIN MARKET ANALYSIS BY PRODUCT
    6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CONSTRUCTION
    9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
    11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
    12. 6.12 CONSTRUCTION, BY PROCEDURE, 2024 (% SHARE)
    13. 6.13 CONSTRUCTION, BY PROCEDURE, 2024 TO 2035 (USD Million)
    14. 6.14 CONSTRUCTION, BY END USER, 2024 (% SHARE)
    15. 6.15 CONSTRUCTION, BY END USER, 2024 TO 2035 (USD Million)
    16. 6.16 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
    17. 6.17 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
    18. 6.18 CONSTRUCTION, BY PRODUCT, 2024 (% SHARE)
    19. 6.19 CONSTRUCTION, BY PRODUCT, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PROCEDURE, 2025-2035 (USD Million)
      2. 7.2.2 BY END USER, 2025-2035 (USD Million)
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
      4. 7.2.4 BY PRODUCT, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Spain Endoscopic Retrograde Cholangiopancreatography Market Segmentation

Spain Endoscopic Retrograde Cholangiopancreatography Market By Procedure (USD Million, 2025-2035)

  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dilatation
  • Pancreatic Duct Stenting
  • Others

Spain Endoscopic Retrograde Cholangiopancreatography Market By End User (USD Million, 2025-2035)

  • Hospitals & Clinics
  • Ambulatory Surgical Centers

Spain Endoscopic Retrograde Cholangiopancreatography Market By Application (USD Million, 2025-2035)

  • Bile Duct
  • Pancreas
  • Others

Spain Endoscopic Retrograde Cholangiopancreatography Market By Product (USD Million, 2025-2035)

  • Endoscopes
  • Endotherapy Devices
  • Catheters
  • Stents
  • Balloons
  • Guiding Wires
  • Others
  • Imaging Devices
  • Energy Devices

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.